Bone Biologics Corporation (BBLG)

Price & Market Data

Price: $1.22

Daily Change: -$0.01 / 0.82%

Daily Range: $1.22 - $1.38

Market Cap: $2,190,217

Daily Volume: 24,221

Performance Metrics

1 Week: -3.15%

1 Month: -12.14%

3 Months: 0.82%

6 Months: -19.08%

1 Year: -77.63%

YTD: -18.00%

About Bone Biologics Corporation (BBLG)

Summarized market data for Bone Biologics Corporation (BBLG). Price: 1.22, daily change: -$0.01 / 0.82%. Market cap: 2,190,217. Performance over 3-month and 6-month periods.

Company Details

Employees: 2

Sector: Health technology

Industry: Medical specialties

Country: United States

Details

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Selected stocks

Aethlon Medical, Inc. (AEMD)

Braemar Hotels & Resorts Inc. (BHR)

U.S. Energy Corp. (USEG)

Hongli Group Inc. (HLP)

Ebang International Holdings Inc. (EBON)